Literature DB >> 7430360

Chronic liver disease in transfusion-dependent thalassaemia: hepatitis B virus marker studies.

S De Virgiliis, G Fiorelli, S Fargion, G Cornacchia, G Sanna, P Cossu, V Murgia, A Cao.   

Abstract

The systematic screening of 253 children with transfusion-dependent homozygous beta-thalassaemia revealed a high incidence of hepatitis B virus markers. The highest frequencies of hepatitis B surface antigen (HBsAg) and antibody to hepatitis B core antigen (anti-HBc) were found in the group of patients with the smallest number of transfusions, while the highest frequency of antibody to hepatitis B surface antigen (anti-HBs) was detected in the patients who had had the largest number of transfusions. Follow-up of these patients showed (a) a high incidence of acute hepatitis B, which was mainly subclinical; (b) normal hepatitis B surface antigen clearance and normal antibody to hepatitis B surface development; and (c) a high frequency of increased transaminase values for over six months. In all the subjects with persistently high transaminase, histological examination revealed chronic persistent hepatitis or chronic active hepatitis. Apart from two cases of chronic active hepatitis with no B virus markers, and two cases of chronic persistent hepatitis with HBsAg and anti-HBc in the serum, all these subjects were anti-HBs positive but HGsAg and anti-HBc negative.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7430360      PMCID: PMC1146291          DOI: 10.1136/jcp.33.10.949

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  20 in total

1.  Immunogenetic factors in thalassemia and hepatitis B infection. A multicentre study.

Authors:  M S Schanfield; G Scalise; I Economidou; C B Modell; C Bate; A J Zuckerman
Journal:  Dev Biol Stand       Date:  1975

2.  Association of antibodies to Australia antigen with anti-Gm antibodies in Italian patients with thalassaemia.

Authors:  B S Blumberg; A Vierucci; W T London; A I Sutnick
Journal:  Nature       Date:  1972-03-03       Impact factor: 49.962

3.  Editorial: Subtypes of hepatitis B antigen: clinical relevance?

Authors:  G L Le Bouvier
Journal:  Ann Intern Med       Date:  1973-12       Impact factor: 25.391

4.  A classification of chronic hepatitis.

Authors:  J De Groote; V J Desmet; P Gedigk; G Korb; H Popper; H Poulsen; P J Scheuer; M Schmid; H Thaler; E Uehlinger
Journal:  Lancet       Date:  1968-09-14       Impact factor: 79.321

5.  Viral hepatitis, type B, DNA polymerase activity and antibody to hepatitis B core antigen.

Authors:  S Krugman; J H Hoofnagle; R J Gerety; P M Kaplan; J L Gerin
Journal:  N Engl J Med       Date:  1974-06-13       Impact factor: 91.245

6.  Antibody to hepatitis B core antigen. A sensitive indicator of hepatitis B virus replication.

Authors:  J H Hoofnagle; R J Gerety; L Y Ni; L F Barker
Journal:  N Engl J Med       Date:  1974-06-13       Impact factor: 91.245

7.  Australia antigen and antibody in transfused children with thalassaemia.

Authors:  A Vierucci; W T London; B S Blumberg; A I Sutnick; F Ragazzini
Journal:  Arch Dis Child       Date:  1972-10       Impact factor: 3.791

8.  Transfusional iron overload: the relationship between tissue iron concentration and hepatic fibrosis in thalassaemia.

Authors:  R A Risdon; M Barry; D M Flynn
Journal:  J Pathol       Date:  1975-06       Impact factor: 7.996

9.  Globin chain synthesis in the alpha thalassemia syndromes.

Authors:  Y W Kan; E Schwartz; D G Nathan
Journal:  J Clin Invest       Date:  1969-11       Impact factor: 14.808

10.  Prevalence of Au-Ag and Au-Ab in transfused children with thalassaemia in Greece.

Authors:  C Kattamis; V Syriopoulou; Y Davri-Karamouzi; D Demetriou; N Matsaniotis
Journal:  Arch Dis Child       Date:  1974-06       Impact factor: 3.791

View more
  4 in total

1.  Raised IgE levels in beta-thalassaemia: correlation with splenectomy and hepatitis B virus infection.

Authors:  A Vierucci; M de Martino; M E Rossi; C Vullo; L Borgatti; W T London; B S Blumberg
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

2.  Occult HBV infection in multi transfused thalassemia patients.

Authors:  Jyotsna Sabat; Bhagirathi Dwibedi; Leera Dash; Shantanu Kumar Kar
Journal:  Indian J Pediatr       Date:  2014-06-15       Impact factor: 1.967

3.  Hepatitis C virus antibodies in a long-term follow-up of beta-thalassaemic children with acute and chronic non-A non-B hepatitis.

Authors:  M Resti; C Azzari; M E Rossi; C Vullo; E Zammarchi; A Vierucci
Journal:  Eur J Pediatr       Date:  1992-08       Impact factor: 3.183

4.  Long-term persistence of anti-HBs after hepatitis B immunization in thalassaemic patients.

Authors:  P Dentico; R Buongiorno; A Volpe; A Zavoianni; D De Mattia; V Sabato
Journal:  Infection       Date:  1992 Sep-Oct       Impact factor: 3.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.